![Frontiers | Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy Frontiers | Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy](https://www.frontiersin.org/files/Articles/697876/fcimb-11-697876-HTML/image_m/fcimb-11-697876-g001.jpg)
Frontiers | Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy
![Las misteriosas mutaciones que hacen de delta la variante del virus de covid más contagiosa hasta ahora | Kaiser Health News Las misteriosas mutaciones que hacen de delta la variante del virus de covid más contagiosa hasta ahora | Kaiser Health News](https://khn.org/wp-content/uploads/sites/2/2021/07/51269164330_2d624c2d70_o.png)
Las misteriosas mutaciones que hacen de delta la variante del virus de covid más contagiosa hasta ahora | Kaiser Health News
![Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern - eBioMedicine Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern - eBioMedicine](https://www.thelancet.com/cms/attachment/c798169c-fd55-43b9-94a2-092367281558/gr1_lrg.jpg)
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern - eBioMedicine
![Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests - ScienceDirect Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666379121001543-fx1.jpg)
Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests - ScienceDirect
![Cancers | Free Full-Text | Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All Cancers | Free Full-Text | Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All](https://www.mdpi.com/cancers/cancers-12-01554/article_deploy/html/images/cancers-12-01554-g001.png)
Cancers | Free Full-Text | Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All
![Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies | Blood Cancer Journal Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-019-0210-z/MediaObjects/41408_2019_210_Fig1_HTML.png)
Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies | Blood Cancer Journal
![Mouse Monoclonal Antibody against Human IFN-Alpha/Beta Receptor 1, Clone MMHAR-3 | PBL Assay Science Mouse Monoclonal Antibody against Human IFN-Alpha/Beta Receptor 1, Clone MMHAR-3 | PBL Assay Science](https://www.pblassaysci.com/sites/default/files/styles/image_gallery_enlarge/public/2022-07/21370-1_Log%20Flourescence%20Fig%204_.jpg?itok=okPIjAW7)
Mouse Monoclonal Antibody against Human IFN-Alpha/Beta Receptor 1, Clone MMHAR-3 | PBL Assay Science
![Generation and functional characterization of a single-chain variable fragment (scFv) of the anti-FGF2 3F12E7 monoclonal antibody | Scientific Reports Generation and functional characterization of a single-chain variable fragment (scFv) of the anti-FGF2 3F12E7 monoclonal antibody | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-80746-8/MediaObjects/41598_2020_80746_Fig1_HTML.png)
Generation and functional characterization of a single-chain variable fragment (scFv) of the anti-FGF2 3F12E7 monoclonal antibody | Scientific Reports
![Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies | Cell Discovery Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies | Cell Discovery](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41421-021-00347-1/MediaObjects/41421_2021_347_Fig1_HTML.png)